Cell & Gene by Oxford Global’s Post

💊 Despite market dislocation, the #biopharma industry is experiencing positive momentum. 📖 In the first installment of our new biopharma quarterly report series, we analyze the ongoing growth of the #pharmaceuticals market and how it’s being influenced by weight loss drug development and #AI-powered #drug discovery. 💻 Check out the report to get fully up to speed on the biopharma #VC market and companies to watch, then register for our upcoming webinar—taking place live from the J.P. Morgan Healthcare Conference—for even more biopharma coverage. You can get the report and RSVP for our webinar here: https://lnkd.in/gmABiXXB #JPM24

Thoughts on this? >> Genentech ends SHP2 deal with Relay Therapeutics after other pharma exits >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #productmarketing

Thoughts on this? >> Genentech ends SHP2 deal with Relay Therapeutics after other pharma exits >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #biotech #productmarketing

🌐 CellSEP Hosts Global Clinical Trial Liaison from Regeneron 🌐 We at CellSEP had the distinct honor of hosting Novell McGloster, MS.Ed, Global Clinical Trial Liaison from Regeneron.. This meeting marks a significant milestone in our ongoing commitment to fostering collaborative relationships with industry leaders in #biotechnology and #pharmaceuticals. Our discussions centered on groundbreaking advancements in clinical trials and the potential for future collaborative projects that align with our mission of innovation in Cell Isolation and Analytics Laboratories. We are immensely grateful for this opportunity to exchange knowledge and ideas with a global leader in biotech! Potential collaborations like these underscore our dedication to staying at the forefront of advancements in the field, ultimately contributing to the development of life-changing medical therapies. #CellSEP #Regeneron #ClinicalTrials #BiotechCollaboration #researchanddevelopment #innovationinpharma

The European health technology assessment (HTA) landscape is evolving, with new guidelines on statistical analysis set to impact biopharmaceutical companies starting in January 2025. Cencora Pharmalex’s Dr. Michael Hennig sheds light on this critical transition, addressing the evolution of the guidelines and the impact on the future landscape of HTA. https://ow.ly/fAhC50SEux5

Collaboration is a key component of medical innovation. We proudly partner with health research organizations and pharmaceutical companies who share our core values and are dedicated to driving science and technology forward. Discover how we can work together to transform healthcare: https://lnkd.in/eXqkjzGr #clinicalphenotyping #research #clinicalstudies #PGx #pharmacogenomics

Next month, Gary Summers and Andrew Rainboldt will take the virtual stage to share their research and findings on how causal inference can increase the probability of success in clinical trials. Save your spot here: https://lnkd.in/dc-T2xj7 #pharmaceutical #drugdevelopment You'll learn: ➡️ How to use causal inference to understand the impact of clinical design decisions, specifically focusing on biomarkers inclusion criterion and clinical trial success ➡️ The importance of combining quality data with the proper methodologies for more informed decisions ➡️ How to apply state-of-the-art methodologies to clinical trials to uncover underlying causal relationships that can optimize decision-making ➡️ The correlation between biomarkers and the probability of technical and regulatory success

The BIO International Conference provides significant benefits to preclinical CROs and the pharma and biotech industry in several ways: Pharma & Biotech Industry Perspective: Innovation Access: Pharmaceutical and biotech companies can explore innovative solutions and cutting-edge research presented by CROs, which can accelerate their drug development processes. Strategic Collaborations: The conference provides an opportunity to identify and engage with high-quality CROs for outsourcing preclinical studies, enabling companies to focus on their core competencies. Industry Insights: Attendees gain insights into the latest industry trends, regulatory changes, and scientific advancements, helping them stay ahead in a competitive market. Investment Opportunities: Companies can identify promising CROs for investment or acquisition, expanding their capabilities and enhancing their research and development pipelines. Overall, the BIO International Conference is a crucial event that fosters collaboration, innovation, and growth across the preclinical CRO and pharmaceutical/biotech industries. We are there......hope to connect and having a meaningful conversation with you. #BIO2024 #PreclinicalResearch #CRO #Pharmaceuticals #Biotechnology #DrugDevelopment #HealthcareInnovation #Networking #Collaboration #BiotechIndustry #PharmaIndustry #ResearchAndDevelopment #ClinicalTrials #LifeSciences #MedicalResearch Yashas Chandra Ashok Malavalli

𝗙𝗶𝗲𝗹𝗱 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗜𝗺𝗽𝗮𝗰𝘁 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝘀 𝗶𝗻 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲 𝘁𝗼 𝘁𝗵𝗲 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 The environment is changing, the way we are communicating with physicians is changing: Sooner or later we ill need to adapt our impact measure, too! Jodi Tainton and I will discuss why some commonly used metrics don't work as well as we thought, and in which directions we should adjust the measurements. #msl #medicalscienceliaison #mslmanager #mslcareer #mslexcellence #mslmentor #mslcoach -------------------------------- ♟️ My name is Maja. 💊 Supporting you to master the MSL profession to embark a successful career in Medical Affairs. 💊 Mentoring and consulting on the role of the Medical Science Liaison (MSL) ➡️send a message on LinkedIn Liked this post? Want to see more? ➡️ Ring the 🔔 on my Profile ➡️ Follow me / Connect with me